Last reviewed · How we verify

Typhoid fever — Treatment Landscape & Competitive Intelligence

Typhoid fever (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Typhoid fever, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Cipro ciprofloxacin Bayer AG Fluoroquinolone antibiotic DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A 1987-10-22
Chlorocidin CHLORAMPHENICOL Parkedale Amphenicol-class Antibacterial Cytochrome P450 3A4 1950-01-01
Chloromycetin chloramphenicol succinate Parkedale Amphenicol-class Antibacterial 1950-01-01
Ofloxacine Ofloxacine Assistance Publique - Hôpitaux de Paris Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1
Ciprofloxacine Ciprofloxacine Poitiers University Hospital DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 2 drugs in Typhoid fever
  2. Parkedale · 2 drugs in Typhoid fever
  3. Assistance Publique - Hôpitaux de Paris · 1 drug in Typhoid fever
  4. Bayer AG · 1 drug in Typhoid fever
  5. Poitiers University Hospital · 1 drug in Typhoid fever

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Typhoid fever:

Cite this brief

Drug Landscape (2026). Typhoid fever — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/typhoid-fever. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing